#NASHDay
The worldwide prevalence of Non-alcoholic Steatohepatitis (NASH) in patients with Type 2 Diabetes Mellitus (DM).
https://liverwellness.ie/wp-content/uploads/2018/06/Worldwide-prevalence-of-NASH-in-T2DM.pdf

#NASHDay
Substantial healthcare utilization (HCU) and costs among non-alcoholic steatohepatitis (NASH)
patients with comorbid diabetes mellitus (DM)
https://liverwellness.ie/wp-content/uploads/2018/06/US-Healthcare-costs-T2DM-and-NASH-cirrhosis.pdf

#NASHDay
OVERWHELMING SUCCESS OF FIRST INTERNATIONAL NASH DAY PAVES WAY FOR A PROMISING EDITION IN 2019
https://www.the-nash-education-program.com/wp-content/uploads/2018/06/2018.06.14-PR-EN-NASH-Day-Success-FINAL2.pdf

#NASHDay
Diabetes and Liver Health - After assessing more than 400 patients with NAFLD, we discovered that 1 out of 4 patients had advanced fibrosis or cirrhosis. In addition, 1 out of 3 of these patients had type 2 diabetes. We need to raise awareness among the diabetes community.

https://liverwellness.ie/wp-content/uploads/2017/11/Diabetes-Liver-Health-A5-Flyer-v.2.pdf

#NASHDay

#NASHDay

#NASHDay 👨 #Patient voice 📢 "#Diet is a big thing [...] Because I am #diabetic, I have been trying to balance the 2 #conditions." #Moment # #Prevention #Health #PublicHealth #Testimony #Liver #PatientAdvocacy

The hidden dangers of Fatty Liver Disease
#NASHDay
https://liverwellness.ie/wp-content/uploads/2017/10/NAFLD-article-by-SN.pdf

#NASHDay

#NASHDay WEBTV Channel
Tune in to the WEBTV program with an alternation of expert interviews, reports and educational videos on NASH.
https://www.youtube.com/channel/UCj1eqAIJuP5K-zOaHR33gxg

The NASH Education Program™ is an endowment fund aimed at developing and managing relevant disease awareness actions in the NASH space. Learn more on: https:...

#NashDay
https://www.youtube.com/watch?time_continue=4&v=_S8miEbNuuw

In this first part, Stephen A. Harrison, MD, Medical Director of Pinnacle Clinical Research, San Antonio, introduces us to NAFLD (Non Alcoholic Fatty Liver D...